Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

Tumor indoleamine 2,3-dioxygenase (IDO) promotes immunosuppression by direct action on effector T cells and Tregs and through recruitment, expansion and activation of myeloid-derived suppressor cells (MDSCs). Targeting of MDSCs is clinically being explored as a therapeutic strategy, though optimal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmgaard, Rikke B., Zamarin, Dmitriy, Lesokhin, Alexander, Merghoub, Taha, Wolchok, Jedd D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856741/
https://www.ncbi.nlm.nih.gov/pubmed/27211548
http://dx.doi.org/10.1016/j.ebiom.2016.02.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856741/
https://www.ncbi.nlm.nih.gov/pubmed/27211548
http://dx.doi.org/10.1016/j.ebiom.2016.02.024

Ejemplares similares